{"id": "1341625901667250178", "creation": 1608703515.0, "user_id": "285030132", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 8, "reply_count": 6, "like_count": 103, "quote_count": 2}}, "text": "#Jubilantlife CDMO on Ampligen (therapeutic angles)\n\n\ud83d\udc89Awarded FDA\u2019s ODD status for pancreatic cancer-17 Dec2020\n\n\ud83d\udc89Advancing CTs of Ampligen as potential protective prophylaxis &amp; an early-onset treatment for #COVID19\n\n\ud83d\udc89Japan is evaluating as potential COVID19 #vaccine adjuvant https://t.co/ttPb5oCcXb", "first_save": 1634559108.199414, "hashtags": ["#JUBILANTLIFE", "#COVID19", "#VACCINE"]}